Update on treatment of essential tremor (Q39379129)

11 September 2017

title

Update on treatment of essential tremor (English)

1 reference

11 September 2017

Theresa A Zesiewicz

1 reference

11 September 2017

Jessica D Shaw

1 reference

11 September 2017

Kevin G Allison

1 reference

11 September 2017

Joseph S Staffetti

1 reference

11 September 2017

Michael S Okun

1 reference

11 September 2017

Kelly L Sullivan

1 reference

11 September 2017

publication date

1 August 2013

1 reference

Current treatment options in neurology

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

410-423

1 reference

Central mechanisms of tremor

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Prevalence of essential tremor in three elderly populations of central Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Essential tremor--neurodegenerative or nondegenerative disease towards a working definition of ET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gait abnormality in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Treatment of patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Essential tremor: an overdiagnosed condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Effect of the beta adrenergic blocking agent propranolol on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Phenylethylmalonamide in essential tremor. A double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Primidone in essential tremor of the hands and head: a double blind controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Topiramate in essential tremor: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

beta-Adrenoreceptor antagonists in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Efficacy of alprazolam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Levetiracetam is not effective for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

The effect of levetiracetam on essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Double-blind controlled trial of gabapentin in essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Metoprolol and propranolol in essential tremor: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Zonisamide for essential tremor: an evaluator-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Review: A review of the use of zonisamide in Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Long-term effects of deep brain stimulation for essential tremor with subjective and objective quantification via mailed-in questionnaires

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Long-term benefits in quality of life after unilateral thalamic deep brain stimulation for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

A randomized trial of deep-brain stimulation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Long-term evaluation of deep brain stimulation of the thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Stereotactic thalamotomy for medically intractable essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gamma knife radiosurgery for movement disorders: a concise review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gamma Knife thalamotomy for tremor in the magnetic resonance imaging era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gamma Knife Thalamotomy for Parkinson Disease and Essential Tremor: A Prospective Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gamma knife thalamotomy for disabling tremor: a blinded evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Complications of Gamma Knife Surgery for Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Gamma Knife thalamotomy for treatment of essential tremor: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Most of the Quality of Life in Essential Tremor Questionnaire (QUEST) psychometric properties resulted in satisfactory values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-013-0239-4

Atenolol vs. propranolol in essential tremor. A controlled, quantitative study

21 January 2018

1 reference

12 December 2020

The effect of nimodipine on essential tremor

1 reference

12 December 2020

Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up

1 reference

12 December 2020

Stereotactic ventral intermedial thalamotomy for the treatment of essential tremor: results of a series of 37 patients

1 reference

12 December 2020

Clinical implications of warfarin interactions with five sedatives

1 reference

12 December 2020

Nadolol in essential tremor

1 reference

12 December 2020

beta-Adrenoceptor antagonists and essential tremor

1 reference

12 December 2020

A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor

1 reference

12 December 2020

ACTION OF PRONETHALOL ON PARKINSONIAN TREMOR

1 reference

12 December 2020

Acute and chronic effects of propranolol and primidone in essential tremor

1 reference

12 December 2020

Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis.

1 reference

12 December 2020

Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

1 reference

12 December 2020

Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor

1 reference

12 December 2020

Treatment of Essential Tremor: Are there Issues We are Overlooking?

1 reference

12 December 2020

New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide

1 reference

12 December 2020

Long-acting propranolol in essential tremor

1 reference

12 December 2020

Kinetic predominant essential tremor: successful treatment with clonazepam

1 reference

12 December 2020

Randomized trial comparing primidone initiation schedules for treating essential tremor

1 reference

12 December 2020

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

10.1007/S11940-013-0239-4

Identifiers

DOI

1 reference

release_cmpn4c5jvzhbvn7m232hiorrvq

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cmpn4c5jvzhbvn7m232hiorrvq

24 November 2022

mapped directly with Wikidata item

1 reference